MedPath

Clinical Observation of Compound Shanhaidan Granules in the Treatment of Blood Stasis Type Senile Hypertensio

Phase 4
Recruiting
Conditions
Blood Stasis Type Senile Hypertension
Registration Number
ITMCTR2000003918
Lead Sponsor
ongHua Hospital Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. The patients with senior hypertension, aged from 60 to 85 years;
2. Meet the diagnostic criteria of Blood Stasis Type in traditional Chinese medicine;
3. The patient has not taken Chinese medicine (including proprietary Chinese medicine) within two weeks;
4. Under the circumstance of understanding the content of this research, participate voluntarily and sign the informed consent form.

Exclusion Criteria

1. Patients with secondary hypertension;
2. Systolic blood pressure>180mmHg;
3. Stroke or myocardial infarction occurred in the past six months;
4. Patients who cannot persist in completing clinical observation;
5. Diseases with increased cardiac output, such as: hyperthyroidism, aortic insufficiency, severe anemia, etc.;
6. Patients with severe organ dysfunction, malignant tumors, and mental disorders;
7. Participate in other clinical research in the past 4 weeks.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CHOL, TG, LDL-C, HDL-C;Ambulatory blood pressure; Efficacy evaluation of TCM syndromes;Dynamic electrocardiogram;
Secondary Outcome Measures
NameTimeMethod
Blood Routine Examination;Urine Routine Examination;
© Copyright 2025. All Rights Reserved by MedPath